{"id":"https://openalex.org/W48427347","doi":null,"title":"Bcrp does not influence transport of nitrofurantoin across the blood-brain barrier at different ages","display_name":"Bcrp does not influence transport of nitrofurantoin across the blood-brain barrier at different ages","publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W48427347","mag":"48427347"},"language":"en","primary_location":{"id":"mag:48427347","doi":null,"is_oa":false,"landing_page_url":"http://www.diva-portal.org/smash/record.jsf?pid=diva2%3A249223","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000349457","display_name":"J\u00f6rgen Bengtsson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J\u00f6rgen Bengtsson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057823553","display_name":"Chisato Mukai","orcid":"https://orcid.org/0000-0001-8621-1068","observed_orcids":["https://orcid.org/0000-0001-8621-1068"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chisato Mukai","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8621-1068","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014830673","display_name":"Shinji Kitagaki","orcid":"https://orcid.org/0000-0001-7496-7773","observed_orcids":["https://orcid.org/0000-0001-7496-7773"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shinji Kitagaki","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7496-7773","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014896119","display_name":"Naoki Miyakoshi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Naoki Miyakoshi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026158271","display_name":"Tetsuya Terasaki","orcid":"https://orcid.org/0000-0002-6332-7575","observed_orcids":["https://orcid.org/0000-0002-6332-7575"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tetsuya Terasaki","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6332-7575","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048779515","display_name":"Sven Erik Bj\u00f6rkman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sven Bj\u00f6rkman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5091428143","display_name":"Margareta Hammarlund\u2010Udenaes","orcid":"https://orcid.org/0000-0002-9181-1321","observed_orcids":["https://orcid.org/0000-0002-9181-1321"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Margareta Hammarlund\u2010Udenaes","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9181-1321","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.00573298,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9574999809265137,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9574999809265137,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","score":0.0414000004529953,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/blood-brain-barrier","display_name":"blood-brain barrier","score":0.9449999928474426},{"id":"https://openalex.org/keywords/drug-transport","display_name":"drug transport","score":0.6470000147819519},{"id":"https://openalex.org/keywords/abcg2","display_name":"ABCG2","score":0.8730000257492065},{"id":"https://openalex.org/keywords/nitrofurantoin","display_name":"nitrofurantoin","score":0.9649999737739563},{"id":"https://openalex.org/keywords/morphine","display_name":"morphine","score":0.9860000014305115},{"id":"https://openalex.org/keywords/morphine-3-glucuronide","display_name":"morphine-3-glucuronide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/brain-development","display_name":"brain development","score":0.7599999904632568},{"id":"https://openalex.org/keywords/age-related-changes","display_name":"age-related changes","score":0.7310000061988831},{"id":"https://openalex.org/keywords/oat3","display_name":"OAT3","score":0.9129999876022339},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.871999979019165},{"id":"https://openalex.org/keywords/occludin","display_name":"occludin","score":0.7879999876022339},{"id":"https://openalex.org/keywords/brain-to-plasma-ratio","display_name":"brain-to-plasma ratio","score":0.628000020980835},{"id":"https://openalex.org/keywords/microdialysis","display_name":"microdialysis","score":0.7670000195503235},{"id":"https://openalex.org/keywords/drug-distribution-in-brain","display_name":"brain drug distribution","score":0.4580000042915344},{"id":"https://openalex.org/keywords/knockout-mice","display_name":"knockout mice","score":0.49399998784065247}],"concepts":[{"id":"https://openalex.org/C50156730","wikidata":"https://www.wikidata.org/wiki/Q3856966","display_name":"Microdialysis","level":3,"score":0.922559380531311},{"id":"https://openalex.org/C2777389121","wikidata":"https://www.wikidata.org/wiki/Q81225","display_name":"Morphine","level":2,"score":0.6695867776870728},{"id":"https://openalex.org/C2778402981","wikidata":"https://www.wikidata.org/wiki/Q221694","display_name":"Blood\u2013brain barrier","level":3,"score":0.6546455025672913},{"id":"https://openalex.org/C512196","wikidata":"https://www.wikidata.org/wiki/Q4650095","display_name":"Abcg2","level":5,"score":0.6411647796630859},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6176520586013794},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6033762097358704},{"id":"https://openalex.org/C2775962179","wikidata":"https://www.wikidata.org/wiki/Q2013337","display_name":"Occludin","level":3,"score":0.6023377776145935},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.5561283826828003},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5540468096733093},{"id":"https://openalex.org/C149011108","wikidata":"https://www.wikidata.org/wiki/Q652985","display_name":"Transporter","level":3,"score":0.546952486038208},{"id":"https://openalex.org/C2776678969","wikidata":"https://www.wikidata.org/wiki/Q28209167","display_name":"Organic anion-transporting polypeptide","level":4,"score":0.4401698410511017},{"id":"https://openalex.org/C2778707650","wikidata":"https://www.wikidata.org/wiki/Q412902","display_name":"P-glycoprotein","level":4,"score":0.425799697637558},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.3001765012741089},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.29843705892562866},{"id":"https://openalex.org/C28406088","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Extracellular","level":2,"score":0.2829558253288269},{"id":"https://openalex.org/C44312359","wikidata":"https://www.wikidata.org/wiki/Q286958","display_name":"ATP-binding cassette transporter","level":4,"score":0.2563902735710144},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.25077497959136963},{"id":"https://openalex.org/C177779419","wikidata":"https://www.wikidata.org/wiki/Q1053832","display_name":"Tight junction","level":2,"score":0.1627330183982849},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.15641003847122192},{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:48427347","doi":null,"is_oa":false,"landing_page_url":"http://www.diva-portal.org/smash/record.jsf?pid=diva2%3A249223","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9789000153541565}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W72094006","https://openalex.org/W46793889","https://openalex.org/W1989611977","https://openalex.org/W2152377543","https://openalex.org/W176293022","https://openalex.org/W3151508073","https://openalex.org/W2075295182","https://openalex.org/W1542480594","https://openalex.org/W2120175098","https://openalex.org/W3027257567"],"abstract_inverted_index":{"The":[0,104,253],"developmental":[1],"aspect":[2],"of":[3,42,47,60,69,75,89,108,124,132,171,199,222,241,256,314],"drug":[4,323],"transport":[5,21,68,160,170],"across":[6,72,161,259,335],"the":[7,43,58,67,73,122,127,145,158,162,169,172,195,220,238,260,265,287,311,326,336],"blood-brain":[8],"barrier":[9],"(BBB)":[10],"was":[11,14,31,100,118,134,262],"investigated.":[12],"Microdialysis":[13,50],"used":[15,55,111],"to":[16,33,56,66,144,247,269,281,295,300,325],"study":[17,30,57],"unbound":[18,257],"morphine":[19,91,125,133,159,173,342],"BBB":[20,74,163,261,302,337],"at":[22],"different":[23,48],"ages":[24],"in":[25,28,38,45,82,95,105,115,126,136,142,148,251,264,286,291,306,329],"sheep.":[26],"An":[27],"vitro":[29,307],"performed":[32],"find":[34],"differentially":[35,190],"expressed":[36,191],"genes":[37,316],"brain":[39,44,239],"capillary-rich":[40],"fractions":[41],"rats":[46,76,84],"ages.":[49],"and":[51,85,92,97,102,139,202,225],"brain-to-plasma":[52],"ratios":[53],"were":[54],"contribution":[59,285],"breast":[61],"cancer":[62],"resistance":[63],"protein":[64,249],"(Bcrp)":[65,201],"nitrofurantoin":[70],"(NTF)":[71],"during":[77],"development":[78],"as":[79,81,112],"well":[80],"adult":[83,140,266],"mice.":[86],"A":[87,129],"method":[88],"analysing":[90],"its":[93],"metabolites":[94],"plasma":[96],"microdialysis":[98,116],"samples":[99],"developed":[101],"validated.":[103],"vivo":[106,330],"recovery":[107],"deuterated":[109],"morphine,":[110],"a":[113,283],"calibrator":[114],"experiments,":[117],"not":[119,178,232,279,344],"affected":[120],"by":[121,274],"presence":[123],"tissue.":[128],"net":[130],"influx":[131,152],"observed":[135],"premature":[137],"lambs":[138],"sheep,":[141],"contrast":[143],"efflux":[146,273],"seen":[147],"other":[149,275],"species.":[150],"This":[151],"decreased":[153,243],"with":[154,165,180,192,209,234,244,298,318,339],"age,":[155,319],"indicating":[156],"that":[157,185,310,333],"changes":[164],"age.":[166,181,193,235],"In":[167,218,236,304],"contrast,":[168,219],"metabolite":[174],"morphine-3-glucuronide":[175],"(M3G)":[176],"did":[177,231,278],"change":[179,233],"Microarray":[182],"data":[183],"indicated":[184],"several":[186],"active":[187],"transporters":[188],"are":[189],"Moreover,":[194],"mRNA":[196],"expression":[197,221,312],"levels":[198,313],"Abcg2":[200],"Slc22a8":[203],"(organic":[204],"anion":[205],"transporter":[206],"3)":[207],"changed":[208,317,338],"age":[210,245,340],"when":[211],"quantified":[212],"using":[213],"real-time":[214],"polymerase":[215],"chain":[216],"reaction.":[217],"Abcb1":[223],"(P-glycoprotein)":[224],"occludin":[226],"(a":[227],"tight":[228],"junction":[229],"protein)":[230],"rats,":[237],"distribution":[240,324,334],"NTF":[242,258,301],"due":[246,268],"increased":[248],"binding":[250],"plasma.":[252],"concentration":[254],"ratio":[255],"low":[263],"rat,":[267],"intra-brain":[270],"metabolism":[271],"and/or":[272],"transporters.":[276],"Bcrp":[277],"appear":[280],"have":[282],"significant":[284],"developing":[288],"rat":[289],"or":[290,347],"knock-out":[292],"mice":[293],"compared":[294],"wild-type":[296],"controls":[297],"regard":[299],"transport.":[303],"conclusion,":[305],"studies":[308,331],"showed":[309,332],"some":[315],"presumably":[320],"affecting":[321],"subsequent":[322],"brain.":[327],"Further,":[328],"for":[341,345],"but":[343],"M3G":[346],"NTF.":[348]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}